RIPK3 and familial dilated cardiomyopathy: Unexpectedly, we found that the mRNA level of RIP3 failed to exhibit significant alteration in the heart tissues of DCM patients, AB rats, and Ang-II or PE-treated cardiomyocytes (Figure S1, A–D).